产品特点
Filename: Dokument1
1/13
SUMMARY OF PRODUCT CHARACTERISTICS
Baycox Bovis
RENEWAL
DK/V/0109/001/R/001
DAY 90
Dokument1
2/13
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Baycox Bovis
50mg/ml oral suspension
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains:
Active substance:
Toltrazuril
50.0 mg
EXCIPIENT(S):
Sodium benzoate (E211)
2.1 mg
Sodium propionate (E281)
2.1 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension
White or yellowish suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle (calves on dairy farms)
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the prevention of clinical signs of coccidiosis and reduction of coccidia shedding in housed
calves replacing cows producing milk for human consumption (dairy cows) on farms with a
confirmed history of coccidiosis caused by _Eimeria bovis_ or _Eimeria zuernii_.
4.3
CONTRAINDICATIONS
For environmental reasons:
Do not use in calves weighing more than 80 kg bodyweight.
Do not use in fattening units such as veal or beef calves
For more details see sections 4.5, other precautions and section 5, environmental properties.
4.4
SPECIAL WARNINGS
As with any antiparasiticide frequent and repeated use of antiprotozoals from the same class
may lead to the development of resistance.
It is recommended to treat all calves in a pen
Hygienic measures may reduce the risk of bovine coccidiosis. It is therefore, recommended
to improve concomitantly the hygienic conditions i
阅读完整的文件
产品特点 